Z944: a first in class T-type calcium channel modulator for the treatment of pain.
about
The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic PotentialGenetic disruption of voltage-gated calcium channels in psychiatric and neurological disordersRedox-Dependent Modulation of T-Type Ca(2+) Channels in Sensory Neurons Contributes to Acute Anti-Nociceptive Effect of Substance PA randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic painInflammatory mediator bradykinin increases population of sensory neurons expressing functional T-type Ca(2+) channels.Heantos-4, a natural plant extract used in the treatment of drug addiction, modulates T-type calcium channels and thalamocortical burst-firing.A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain.Targeting voltage-gated calcium channels in neurological and psychiatric diseases.Surfen is a broad-spectrum calcium channel inhibitor with analgesic properties in mouse models of acute and chronic inflammatory pain.Regulation of the T-type Ca(2+) channel Cav3.2 by hydrogen sulfide: emerging controversies concerning the role of H2 S in nociception.Recent advances in the development of T-type calcium channel blockers for pain intervention.Synthesis and characterization of a disubstituted piperazine derivative with T-type channel blocking action and analgesic properties.Modulation of T-type Ca2+ channels by Lavender and Rosemary extracts.
P2860
Q26781422-99F696D7-3416-450D-83DE-D86EE93C260AQ26783154-DF197144-0AEC-4B3D-BF01-CD79D5AE7F6EQ27308025-E7DD700B-1651-4957-9A7E-BD22D5C56122Q36628308-EDB02550-C3B1-4A92-A3CA-637FDB2FE35AQ36823117-5CDBF5B9-03D2-4A4B-98EA-E0C2F76B6495Q37476509-3B2148D7-2952-43D8-89E0-AC3601FAC605Q38292647-B5A78B22-9038-451E-8013-29D481B258F4Q38626606-A7EE0573-C62B-4AED-BC53-3C2D64FC289BQ38701037-1D8F6D8F-5B29-441B-BF2F-E1947D5FA36FQ38709498-D263B98E-E4F7-456C-9203-D6900BBD1179Q39154350-C802A67C-92AF-4224-89BA-48722120D5D5Q39174362-C1B562F4-DC3B-4875-86AE-4AACC076B5A8Q44921188-9678582B-C23F-475F-BF37-21266EB9005C
P2860
Z944: a first in class T-type calcium channel modulator for the treatment of pain.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Z944: a first in class T-type calcium channel modulator for the treatment of pain.
@ast
Z944: a first in class T-type calcium channel modulator for the treatment of pain.
@en
type
label
Z944: a first in class T-type calcium channel modulator for the treatment of pain.
@ast
Z944: a first in class T-type calcium channel modulator for the treatment of pain.
@en
prefLabel
Z944: a first in class T-type calcium channel modulator for the treatment of pain.
@ast
Z944: a first in class T-type calcium channel modulator for the treatment of pain.
@en
P356
P1476
Z944: a first in class T-type calcium channel modulator for the treatment of pain.
@en
P2093
P2860
P356
10.1111/JNS.12080_2
P478
19 Suppl 2
P577
2014-10-01T00:00:00Z